CANTILLON MARC enters REVIVA PHARMACEUTICALS HOLDINGS, INC. with 15.72K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 12/18/2020ACC: 0001104659-20-137404
Officer· Chief Medical Officer
Since Dec 2020
15.72K
Baseline shares
34% direct
5.39K
Direct ownership
1 position
53.29K
Derivative underlying
3 instruments
2
Security positions
10.33K indirect
Non-Derivative Holdings2
Common Stock
IndirectShares owned10.33K
Common Stock
DirectShares owned5.39K
Total
5.39K direct·10.33K indirect15.72K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.33K | Indirect |
| Common Stock | 5.39K | Direct |
| Total | 15.72K | 5.39K direct·10.33K indirect |
Derivative Holdings3
Stock Option
DirectUnderlying security
Common Stock
Underlying shares
15.23K
Shares owned
N/A
Exercise price
11.89
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Stock
Underlying shares
7.61K
Shares owned
N/A
Exercise price
31.33
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Stock
Underlying shares
30.45K
Shares owned
N/A
Exercise price
11.89
Expiration
—
Exercise window
—
Total
Underlying
53.29K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock | 11.89 | — | — | 15.23K | N/A |
| Stock Option Direct | Common Stock | 31.33 | — | — | 7.61K | N/A |
| Stock Option Direct | Common Stock | 11.89 | — | — | 30.45K | N/A |
| Total | 53.29K | 0.00 | ||||